These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 14250544)

  • 1. [ACTION OF CERTAIN L-DOPA/5-HTP DECARBOXYLASE INHIBITORS ON HYPOTHALAMO-HYPOPHYIAL NEUROSECRETION IN THE RAT].
    SOULAIRAC A; SOULAIRAC ML
    C R Seances Soc Biol Fil; 1964; 158():1445-7. PubMed ID: 14250544
    [No Abstract]   [Full Text] [Related]  

  • 2. [THE ROLE OF CATECHOLAMINES IN THE CONTROL OF HYPOTHALAMIC NEUROSECRETION. EFFECTS OF RESERPINE COMPOUNDS, MONOAMINE OXIDASE INHIBITORS AND D-1 DOPA 5-HTP DECARBOXYLASE INHIBITORS].
    CAHN J; HEROLD M
    Agressologie; 1964; 5():451-63. PubMed ID: 14192331
    [No Abstract]   [Full Text] [Related]  

  • 3. [ACTION OF 5-HTP/DOPA DECARBOXYLASE INHIBITORS ON DIURESIS, URINARY ELECTROLYTES AND RELEASE OF THE ANTIDIURETIC HORMONE].
    CAHN J; HEROLD M; BARRE N
    C R Seances Soc Biol Fil; 1964; 158():1331-5. PubMed ID: 14210566
    [No Abstract]   [Full Text] [Related]  

  • 4. [THE ROLE OF CATECHOLAMINES IN THE CONTROL OF HYPOTHALAMIC NEUROSECRETION. EFFECTS OF RESERPINE, A MONOAMINE OXIDASE INHIBITOR AND DIFFERENT D-1 DOPA 5-HTP DECARBOXYLASE INHIBITORS].
    SOULAIRAC A; SOULAIRAC ML
    Agressologie; 1964; 5():465-71. PubMed ID: 14192332
    [No Abstract]   [Full Text] [Related]  

  • 5. [COMPARATIVE ACTION OF 2 DECARBOXYLASE INHIBITORS ON THE METABOLISM OF ENDOGENOUS AND EXOGENOUS 5-HYDROXYTRYPTAMINE].
    KUNZ E
    Arch Int Pharmacodyn Ther; 1964 Jan; 147():1-8. PubMed ID: 14116929
    [No Abstract]   [Full Text] [Related]  

  • 6. [ACTION OF DIFFERENT INHIBITORS OF L-DOPA-5-HTP DECARBOXYLASE ON AN INDUCED HYPERTHERMIA OF CENTRAL ORIGIN].
    HELBECQUE C; JUILLARD AM; HEROLD M; CAHN J
    C R Seances Soc Biol Fil; 1963 Oct; 157():996-9. PubMed ID: 14092126
    [No Abstract]   [Full Text] [Related]  

  • 7. INHIBITION OF CEREBRAL DECARBOXYLASE AND BEHAVIOUR.
    PLETSCHER A; PRADAM DA; STEINER FA
    Int J Neuropharmacol; 1964 Dec; 3():550-64. PubMed ID: 14344493
    [No Abstract]   [Full Text] [Related]  

  • 8. [ACTION OF ALPHA-METHYL-HYDRAZINO-DOPA AND OF ITS PHOSPHO-5'-PYRIDOXAL HYDRAZINE ON AMINO ACID DECARBOXYLASES].
    GONNARD P; DUHAULT J; FENARD S
    J Neurochem; 1964 Nov; 11():819-24. PubMed ID: 14242333
    [No Abstract]   [Full Text] [Related]  

  • 9. [ANTIHYPERTENSIVE ACTION OF A DOPA-DECARBOXYLASE INHIBITOR: METHYLDOPA].
    BENZI G
    Farmaco Prat; 1963 Dec; 18():688-93. PubMed ID: 14121022
    [No Abstract]   [Full Text] [Related]  

  • 10. [STUDIES ON THE STEREOSPECIFICITY OF THE DECARBOXYLASE INHIBITING ACTION OF ALPHA-METHYLDOPA].
    PUETTER J; KRONEBERG G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1964 Nov; 249():470-8. PubMed ID: 14335181
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacology of several aromatic amino acid decarboxylase inhibitors].
    Uspenskiĭ AE; Dabagov NS; Skoldinov AP
    Biull Eksp Biol Med; 1978 Oct; 86(10):444-7. PubMed ID: 309344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [5-HYDROXYTRYPTOPHAN DOPA DECARBOXYLASE IN NERVOUS AND CARDIAC TISSUES IN THE MOLLUSC HELIX POMATIA. INTERACTION OF SUBSTRATES IN VITRO].
    CARDOT J
    C R Hebd Seances Acad Sci; 1964 Jul; 259():902-4. PubMed ID: 14190531
    [No Abstract]   [Full Text] [Related]  

  • 13. Presence of endogenous inhibitor of aromatic L-amino acid decarboxylase in monkey serum.
    Rahman MK; Togari A; Kojima K; Takahashi K; Nagatsu T
    Mol Cell Biochem; 1984 Aug; 63(1):53-8. PubMed ID: 6333583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EFFECT OF SOME BENZYLHYDRAZINES AND BENZYLOXYAMINES ON DOPA AND 5-HYDROXYTRYPTOPHAN DECARBOXYLASE IN VIVO.
    HANSSON E; FLEMING RM; CLARK WG
    Int J Neuropharmacol; 1964 May; 3():177-88. PubMed ID: 14336525
    [No Abstract]   [Full Text] [Related]  

  • 15. INHIBITORY EFFECTS OF DECARBOXYLASE INHIBITORS ON THE METABOLISM OF TYROSINE-C14 IN THE RAT.
    MORAN JF; SOURKES TL; CHAVEZ B
    Can J Biochem Physiol; 1963 Nov; 41():2376-9. PubMed ID: 14089538
    [No Abstract]   [Full Text] [Related]  

  • 16. DISSOCIATION OF THE DECARBOXYLASE-INHIBITING AND NOREPINEPHRINE-DEPLETING EFFECTS OF ALPHA-METHYL-DOPA, ALPHA-ETHYL-DOPA, 4-BROMO-3-HYDROXY-BENZYLOXYAMINE AND RELATED SUBSTANCES.
    LEVINE RJ; SJOERDSMA A
    J Pharmacol Exp Ther; 1964 Oct; 146():42-7. PubMed ID: 14221224
    [No Abstract]   [Full Text] [Related]  

  • 17. EFFECT OF MONOAMINE RELEASERS AND DECARBOXYLASE INHIBITORS ON ENDOGENOUS 5-HYDROXYINDOLE DERIVATIVES IN BRAIN.
    PLETSCHER A; BURKARD WP; GEY KF
    Biochem Pharmacol; 1964 Mar; 13():385-90. PubMed ID: 14157599
    [No Abstract]   [Full Text] [Related]  

  • 18. On the identity of DOPA decarboxylase and 5-hydroxytryptophan decarboxylase (immunological titration-aromatic L-amino acid decarboxylase-serotonin-dopamine-norepinephrine).
    Christenson JG; Dairman W; Udenfriend S
    Proc Natl Acad Sci U S A; 1972 Feb; 69(2):343-7. PubMed ID: 4536745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A possible feed-back mechanism controlling the biosynthesis of 5-hydroxytryptamine.
    Contractor SF; Jeacock MK
    Biochem Pharmacol; 1967 Oct; 16(10):1981-7. PubMed ID: 5299642
    [No Abstract]   [Full Text] [Related]  

  • 20. MULTIPLE INHIBITORY EFFECTS OF ALPHA-METHYLAMINO ACIDS ON THE METABOLISM OF C14-LABELED TYROSINE, DOPA AND ALPHA-METHYLDOPA.
    MORAN JF; SOURKES TL
    J Pharmacol Exp Ther; 1965 May; 148():252-61. PubMed ID: 14301016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.